During the past decade, Haydarpasa Numune Training and Research Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 8 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haydarpasa Numune Training and Research Hospital" #1 sponsor was "Acibadem University" with 4 trials, followed by "Haydarpasa Numune Training and Research Hospital" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haydarpasa Numune Training and Research Hospital" #1 collaborator was "Bakirkoy Dr. Sadi Konuk Research and Training Hospital" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Haseki Training and Research Hospital" with 1 trials as a collaborator, "Haydarpasa Numune Training and Research Hospital" with 1 trials as a collaborator and "Istanbul Training and Research Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Haydarpasa Numune Training and Research Hospital" are "Crohn Disease" (5 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials), "Axial Spondyloarthritis" (2 trials) and "Blood Transfusion" (2 trials). Many other conditions were trialed in "Haydarpasa Numune Training and Research Hospital" in a lesser frequency.

Most popular intervention types in "Haydarpasa Numune Training and Research Hospital" are "Drug" (12 trials), "Other" (9 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "GED-0301" (3 trials), "Blood transfusion" (2 trials), "Botulinum toxin type A" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Haydarpasa Numune Training and Research Hospital" are 26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Haydarpasa Numune Training and Research Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Haydarpasa Numune Training and Research Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Haydarpasa Numune Training and Research Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".